Adora Life Science Appoints Dr. Clinton D. Morgan as Chief Medical Officer
Adora Life Science has appointed Dr. Clinton D. Morgan as its new full-time Chief Medical Officer. Dr. Morgan will assume his role effective November 1, 2026.
FRANKLIN, Tenn. – Adora Life Science announced that Dr. Clinton D. Morgan will join the company as its full-time Chief Medical Officer. Dr. Morgan will assume his role effective November 1, 2026.
Dr. Morgan previously served on Adora's Board of Directors. His experience in medical leadership and development is expected to support the company's strategic objectives as Adora Life Science focuses on clinical research and drug development.
The appointment enhances Adora's medical expertise as the company grows. Adora aims to advance new therapies for conditions primarily associated with aging.
Dr. Morgan's responsibilities will include overseeing the company's medical strategies and contributing to the design and execution of clinical trials.